Starkey highlights Omega AI hearing aids at EROC

Starkey Middle East and Africa used the Emirates Otolaryngology Conference and Exhibition in Dubai to spotlight Omega AI, a hearing-aid platform positioned around clearer user feedback, discreet design and expanded connectivity, as manufacturers compete to make assistive devices easier to live with day to day. The showcase underlined how incremental hardware cues and software intelligence are becoming central to adoption, not just clinical performance.

At the stand hosted by Starkey MEA, visitors were introduced to Omega AI hearing aids featuring a new system of coloured LED indicators designed to give instant confirmation of device status. A green light signals power and pairing readiness, while red indicates charging or alerts, allowing users to check functionality at a glance without opening a smartphone app or relying on audio prompts. The feature is integrated into the receiver-in-canal RIC RT and the mini receiver-in-canal mRIC R models, formats that remain popular for their balance of performance and discretion.

Executives described the visual indicators as a practical response to everyday user friction, particularly among first-time wearers and older adults who want reassurance that Bluetooth connections are active or batteries are charging correctly. Industry clinicians attending the exhibition noted that such cues can reduce unnecessary clinic visits linked to simple connectivity questions, freeing appointments for more complex care.

Omega AI builds on Starkey’s push to embed artificial intelligence into hearing technology in ways that remain largely invisible to the wearer. The platform uses onboard processing to adapt amplification to changing sound environments, prioritising speech while dampening sudden or sustained background noise. Company representatives said the goal is to minimise manual adjustments so users can focus on conversations rather than controls.

Connectivity remains a core selling point. Omega AI supports seamless wireless pairing with smartphones and other compatible devices, enabling hands-free calls, audio streaming and app-based fine-tuning. The LED confirmation is intended to complement this, offering immediate visual reassurance that wireless links are active. For clinicians, the combination of software intelligence and simple hardware feedback is framed as a way to improve adherence, a long-standing challenge in hearing care.

The launch emphasis reflects wider trends across the sector. Hearing-aid makers are racing to differentiate in a market shaped by ageing populations, greater awareness of hearing health and rapid advances in consumer electronics. Artificial intelligence, low-energy Bluetooth standards and rechargeable batteries have become baseline expectations at the premium end. Manufacturers are now focusing on usability features that address everyday frustrations, from pairing failures to uncertainty over battery status.

The Middle East has emerged as a strategic market in this shift. Rising healthcare investment, expanding private clinic networks and a growing willingness to adopt digital health tools have made the region a testing ground for new features. Dubai’s role as host of Emirates Otolaryngology Conference and Exhibition provided Starkey with access to ear, nose and throat specialists from across the Gulf, Africa and South Asia, many of whom influence purchasing decisions at clinic level.

Clinicians attending the event highlighted that patient expectations are evolving alongside consumer technology habits. Users accustomed to intuitive smartphones and wearables increasingly expect the same clarity and feedback from medical devices. Visual indicators, while simple, were seen as aligning hearing aids more closely with mainstream electronics without compromising discretion.

Starkey representatives also pointed to the importance of balancing visibility with subtlety. The LED lights are designed to be noticeable to the wearer when needed but unobtrusive in social settings, preserving the cosmetic appeal of slim receiver-in-canal designs. This sensitivity to stigma and aesthetics remains a decisive factor in whether patients wear devices consistently.